Online Counselling for Child & Teen ADHD.
Evidence-based ADHD care for children and teenagers aged 5-18, delivered globally via video by certified child psychologists and psychiatrists. Behaviour therapy, parent training, school liaison, and medication when clinically indicated — aligned to the AAP 2019 and NICE NG87 clinical practice guidelines. Wherever your family is, whichever school system your child is in.
- Certified child psychologists
- Registered child psychiatrists
- AAP + NICE guideline-aligned
- Video, audio or chat sessions
- 13+ languages including English
- Any time zone, any device
Click your concern — see who can help.
Instantly matched to the specialist trained for exactly what you're going through.
Understanding Child & Teen ADHD
What is ADHD, really?
ADHD (Attention Deficit Hyperactivity Disorder) is a neurodevelopmental condition that affects how the brain manages attention, impulses, and activity levels. It typically shows up before age 12 and affects an estimated 6-7% of school-aged children per global epidemiological studies. DSM-5 recognises three presentations:
Predominantly Inattentive
The child struggles to sustain attention, follow instructions, organise tasks, or remember daily activities. Often mislabelled as "lazy" or "daydreamer".
- Careless mistakes in schoolwork
- Difficulty listening when spoken to
- Loses things frequently
- Easily distracted
Predominantly Hyperactive-Impulsive
Excessive movement, restlessness, and difficulty waiting or thinking before acting. Often mislabelled as "naughty" or "undisciplined".
- Fidgets, squirms, can't stay seated
- Runs or climbs excessively
- Talks nonstop, blurts answers
- Difficulty waiting turn
Combined Presentation
The most common form — child shows symptoms of both inattention and hyperactivity-impulsivity. Present in roughly 50-75% of diagnosed cases.
- Full range of inattention symptoms
- Plus hyperactivity-impulsivity
- Often more school & social impact
- Higher risk of co-occurring conditions
Source: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR, APA 2022) · ICD-10 clinical modification.
Meet Our Child ADHD Specialists
Verified, credentialed, handpicked for your family.
Every specialist below is background-verified before onboarding. Psychologists are certified/licensed. Psychiatrists are registered with medical council with MD Psychiatry. All have specific training in child & adolescent mental health and years of experience treating ADHD.
Evidence-Based Treatment Approaches
Six approaches, one integrated plan.
Based on AAP 2019 Clinical Practice Guideline and NICE NG87, effective ADHD care combines multiple approaches — never medication alone, never therapy alone. Your child's plan is built around what actually works for their age, presentation, and family context.
Parent Behaviour Training
The first-line treatment for ADHD in children under 12 per AAP. Weekly sessions equip parents with behaviour-management strategies — praise, structured routines, effective commands, calm consequences.
Child Behaviour Therapy
Skill-building sessions with the child — self-regulation, emotional coping, homework routines, social skills. Adapted for developmental age. Delivered in play-based format for younger children.
CBT for Teens
Cognitive Behavioural Therapy adapted for adolescents — thought-behaviour connections, planning skills, emotional regulation, academic strategies, self-esteem work.
School Support & Accommodations
Our care team helps prepare medical documentation for your child's school system and liaises with teachers and counsellors. Includes accommodations for IB, IGCSE, US IEP/504, UK GCSE, CBSE, ICSE and other major systems.
Executive Functioning Coaching
Structured coaching in planning, organising, time management, task initiation, and working memory — the skills schools assume every student has but ADHD makes hard to build.
Medication (when clinically indicated)
For ages 6+ per AAP, methylphenidate is first-line stimulant; atomoxetine is a non-stimulant option. Medication is always a parent's informed choice, requires proper clinical evaluation by a registered psychiatrist, and involves careful monitoring.
HopeQure does not sell or dispense medication. All prescriptions are issued by registered psychiatrists based on proper clinical evaluation and per the prescribing regulations of your country. Stimulant medications are controlled prescription drugs requiring specific clinical documentation.
The Neuroscience Behind ADHD
What's actually different in an ADHD brain?
ADHD isn't a character flaw or a discipline issue — it's a difference in how the brain regulates attention, motivation, and impulse control. Understanding the science helps make sense of why "just try harder" doesn't work, and why the right treatment does.
The four key differences
Simplified from decades of fMRI and neurotransmitter research.
Underactive — the "CEO" of the brain that manages focus and planning develops 2-3 years later.
Lower baseline levels — the reward & motivation neurotransmitter that makes tasks feel worth doing.
Dysregulated — helps sustain attention and filter distractions.
Doesn't switch off properly — the "mind wandering" network stays active during tasks.
Why "try harder" is unfair advice
In an ADHD brain, the prefrontal cortex — the region responsible for planning, prioritising, and inhibiting impulses — develops roughly 2-3 years later than in a typically-developing brain (Shaw et al., NIMH, 2007). A 10-year-old with ADHD may have the executive maturity of a 7-year-old, even though they're academically at grade level.
The other piece is dopamine — the neurotransmitter that signals "this is worth doing". ADHD brains have lower baseline dopamine, which is why boring tasks (schoolwork, chores) feel physically painful to sustain attention on, while stimulating tasks (video games, novelty) hold effortless focus. This is called interest-based attention, and it's neurological — not motivational.
Stimulant medications like methylphenidate work by increasing dopamine availability in the prefrontal cortex, essentially compensating for the biological shortfall. Behaviour therapy works by building compensatory routines that reduce the executive-function load. Both approaches address the underlying biology — from different angles.
Sources: Shaw P. et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA (2007) · Volkow N. Dopamine in ADHD: clinical and neuroimaging studies (JAMA 2009) · Faraone S. et al. Nat Rev Dis Primers (2015).
Transparent Pricing · No Hidden Fees
Session fees & care packages.
Single sessions or structured programmes. Pay per session, or commit to a package for continuity. Money-back guarantee on your first session if not satisfied.
The 8 Executive Function Skills
What ADHD actually makes harder.
ADHD isn't really about attention — it's about executive function, the brain's self-management system. Here are the 8 core skills (per Dawson & Guare, 2018) and what "weak" looks like in a child. The goal of therapy is targeted strengthening, one skill at a time.
Sustained Attention
Keeping focus on a task even when it's boring, difficult, or long.
Response Inhibition
Thinking before acting; resisting the urge to say/do the first thing.
Working Memory
Holding information in mind while doing something else with it.
Emotional Control
Managing feelings to achieve goals, regulating big reactions.
Cognitive Flexibility
Adjusting to change, switching between tasks or perspectives.
Task Initiation
Starting a task without excessive procrastination or need for prompting.
Planning & Prioritising
Breaking a big task into steps and deciding what matters most.
Organisation
Keeping track of belongings, materials, and information systematically.
Symptoms by Age Group
ADHD looks different at different ages.
The core symptoms of ADHD stay the same, but how they show up shifts as a child grows. Tap an age band to see what to watch for.
Ages 5-10 · Elementary school signs
Inattention signals
- Doesn't seem to listen when directly spoken to
- Careless mistakes in schoolwork or writing
- Struggles to finish tasks — moves between activities
- Loses school supplies, water bottle, lunchbox regularly
- Forgets homework, chores, daily routines
- Easily distracted by sounds or movement
Hyperactivity & impulsivity
- Fidgets, taps hands or feet, can't sit still
- Runs or climbs when it's not appropriate
- Talks excessively, interrupts others
- Blurts out answers before question is finished
- Difficulty waiting turn in games or queues
- Acts before thinking (grabs, pushes, runs off)
Ages 11-14 · Middle school signs
Inattention & executive functioning
- Homework battles at home — "just five more minutes"
- Incomplete assignments despite doing the work
- Poor time management — always late, always rushing
- "Spacey" or daydreams during class
- Disorganised backpack, locker, room
- Trouble planning multi-step projects
Behaviour & social
- Restless leg or need to move even while seated
- Blurts out inappropriate comments to teachers/peers
- Peer conflict — misreads social cues, interrupts
- Emotional dysregulation — outbursts, frustration
- Sleep problems — trouble winding down at night
- Starting to show low self-esteem or "I'm just dumb"
Ages 15-18 · High school signs
Academic & executive
- Poor academic performance despite intelligence
- Chronic procrastination on assignments and boards
- Missed deadlines and forgotten deadlines
- Difficulty studying for competitive exams (JEE/NEET)
- Very disorganised study space and notes
- Overwhelmed by long-form projects
Emotional & risk
- Mood dysregulation — quick to frustration or tears
- Risky decision-making — speeding, unsafe choices
- Sleep disturbance — up late, hard to wake
- Low self-esteem, feeling "different" or "broken"
- Higher risk of anxiety, depression, substance use
- Difficulty maintaining friendships and relationships
Symptom clusters adapted from DSM-5-TR criteria and the American Academy of Pediatrics 2019 Clinical Practice Guideline for ADHD (Wolraich et al., Pediatrics).
Free ADHD Assessment Battery
Four validated screeners · pick what fits.
Below are four widely-used, publicly available ADHD assessment instruments — the same ones clinicians use in structured evaluations. Each measures something different. All results are interpreted for you instantly. None diagnoses ADHD — that requires a proper clinical evaluation — but they tell you whether one is worth pursuing.
How often does your child…
Rate each item honestly based on the past 6 months compared to same-age peers.
NICHQ Vanderbilt · DSM-5 ADHD Symptom Screener
The full 18 DSM-5 ADHD criteria (9 Inattention + 9 Hyperactivity/Impulsivity). Cutoff: 6 or more items rated "Often" or "Very Often" in either domain — indicates symptoms consistent with that ADHD presentation.
SNAP-IV-26 · Symptoms + Oppositional Behaviour
Adds 8 oppositional-defiant items (Q19-Q26) on top of DSM-5 ADHD criteria. Cutoffs (from Bussing 2008 US community norms): Inattention avg ≥ 1.78, Hyperactivity avg ≥ 1.44, ODD avg ≥ 1.88 = clinically significant.
If you've already completed the Vanderbilt tab, your Q1-Q18 scores are re-used here — jump to Q19.
WFIRS-P · How much is ADHD affecting your child's life?
Symptom counts don't tell the whole story. WFIRS measures actual functional impact across 6 life domains — the missing piece most families and even some clinicians skip. A key predictor of who needs treatment vs monitoring.
All four instruments are screening tools, not diagnoses. ADHD diagnosis requires a structured clinical evaluation by a qualified psychologist or registered psychiatrist including parent interview, child interaction, teacher input, and differential diagnosis of co-occurring conditions (anxiety, learning disorders, autism, sleep disorders, depression). Cutoff scores are validated for community screening, not confirmation. Your results here can inform your clinician but should not replace their assessment.
Which Path Is Right for Your Child?
Treatment approaches, side by side.
The AAP 2019 guideline is clear: combined treatment (behaviour therapy + medication where age-appropriate) has the strongest evidence for school-age children. Here's how the three main paths compare on the metrics parents care about most.
| Compare on | Behaviour Therapy Only | Combined (Therapy + Medication) | Medication Only |
|---|---|---|---|
| Effect size on core symptoms | Moderate (~0.5) | Strong (~0.85) | Strong (~0.8) |
| Best age suitability | All ages · First-line for ages 4-5 | Recommended ages 6+ | Ages 6+ only |
| Time to visible improvement | 6-12 weeks | 1-4 weeks (medication) + 6-12 wks (therapy) | 1-4 weeks |
| Skills built (last beyond treatment) | High — parent + child skills | High — skills + symptom relief | Low — symptom relief only |
| Ongoing effort required | High (weekly parent work) | Moderate | Low (take medication daily) |
| Side effects | None | Medication-related (see below) | Medication-related |
| Monthly cost (India, approx.) | ₹4,000-8,000 | ₹5,500-10,000 | ₹2,000-5,000 |
| Effect on co-occurring anxiety/depression | High — addresses directly | High — addresses both | Low — may worsen anxiety |
| Sustainability if therapy/med stops | Skills persist | Skills persist; symptoms return without med | Symptoms return within days |
Effect sizes from The MTA Cooperative Group (1999) landmark trial and subsequent meta-analyses referenced in AAP 2019 and NICE NG87. Costs are illustrative ranges based on HopeQure pricing; actual costs vary by treatment intensity, medication choice, and local pharmacy pricing.
If Medication Is Considered · Full Comparison
Understanding ADHD medications, without the jargon.
Medication is one option — not the only option. If your child's psychiatrist recommends medication, here's what you should know about the three most common choices. All prescriptions require video consultation with a registered psychiatrist and periodic monitoring.
Methylphenidate
Atomoxetine
Guanfacine (ER)
The HopeQure Philosophy
ADHD rarely travels alone.
Roughly 60-80% of children with ADHD have at least one co-occurring condition per epidemiological studies. Treating ADHD without checking for these means missing the full picture — and often, the underlying reason a child is struggling. HopeQure screens for and treats them together.
Comorbidity rates from AAP 2019 Clinical Practice Guideline and NICE NG87. Your child's evaluation includes screening for all of these.
The Six Most Common Companions to ADHD
One condition, often many layers.
Because 60-80% of children with ADHD have at least one co-occurring condition, treating ADHD in isolation misses the fuller picture. Here are the six most common — and the specific care approach for each.
ADHD + Anxiety
Anxiety often develops as a secondary reaction to years of ADHD-related failures, criticism, and social difficulty. In some cases anxiety is primary and mimics inattention.
ADHD + Learning Disability
Dyslexia, dyscalculia, or dysgraphia often co-occur. A child may look inattentive when actually they can't process the reading in front of them.
ADHD + Depression
Chronic underperformance and social rejection can lead to depression by adolescence. Depression can also make ADHD symptoms look worse.
ADHD + Oppositional Defiant
Chronic ADHD-related friction with parents, teachers, and peers can escalate into defiant patterns. Untreated ADHD is the biggest driver.
ADHD + Sleep Problems
Trouble falling asleep, night waking, restless sleep. Poor sleep worsens next-day ADHD symptoms — creating a vicious cycle.
ADHD + Autism Spectrum
The two often co-occur — DSM-5 changed rules in 2013 to allow dual diagnosis. Social differences look different in ADHD (impulsive) vs autism (sensory/rigidity).
AI-Powered Care Roadmap
Build your child's personalised care roadmap in 60 seconds.
Answer 5 quick questions. Our AI cross-references AAP 2019 + NICE NG87 guidelines with your child's specific profile to generate a recommended treatment mix, expected timeline, and budget estimate. This is guidance, not diagnosis — but it's a great starting point for a conversation with our clinicians.
How old is your child?
Treatment approach shifts significantly with developmental stage.
What's the primary presentation?
From the age-band symptoms above or your quick-check result. Pick the best fit.
How much is it affecting daily life?
Severity guides intensity of intervention.
Any co-occurring concerns?
Tick all that apply. This shapes which approaches are prioritised.
What's a comfortable monthly budget?
We can build a good plan at every level — this just helps us pick the right intensity.
This tool provides evidence-based guidance from AAP 2019 & NICE NG87 — not a medical diagnosis. Only a qualified, licensed clinical psychologist or registered psychiatrist can diagnose ADHD after proper evaluation.
Transparent Cost Planning
Total cost of care calculator.
Estimate your monthly and annual spend based on the care intensity you choose. Adjust the sliders to see how each choice affects the total. No hidden costs — everything you'd pay HopeQure is included.
Adjust your care mix
Your estimated monthly cost
Estimates based on HopeQure standard pricing. Actual costs vary by expert selected and care intensity. Medication costs are external (pharmacy) and vary by formulation.
What to Expect
From first call to ongoing care.
A structured, transparent process — no surprises. Most families complete the evaluation in 2-3 weeks and are into a working plan by week 4.
Initial Consultation
50-minute conversation. Parent shares concerns and history. Psychologist gets a sense of the child's world. No commitment beyond this call.
Structured Evaluation
1-2 sessions with parent interview, child interaction, Vanderbilt/SNAP-IV parent + teacher questionnaires. Screening for anxiety, learning disorders, sleep.
Care Plan & Report
Written diagnostic report (if ADHD is confirmed) and personalised care plan. School accommodation letter if needed. Medication discussion with psychiatrist if clinically indicated.
Ongoing Care & Review
Weekly parent training, bi-weekly child sessions, quarterly reviews. School liaison as needed. Medication check-ins if prescribed. Adjustments as your child grows.
Support Beyond the Session
Parent guide + school advocacy.
ADHD care doesn't happen in a 50-minute session — it happens at home, at school, and everywhere in between. We equip you for both.
Your child hasn't changed. Your tools have.
Most parents come to us exhausted from trying every strategy and feeling like nothing works. What changes with proper training isn't your child — it's what you have in your toolkit for the moments that matter.
- Structured daily and homework routines that reduce friction
- Effective commands, praise, and consequence systems
- How to explain ADHD to your child (age-appropriate) without shame
- Managing your own frustration and burnout as a parent
- Sibling dynamics and preventing "the ADHD kid" labelling
- School meetings — what to say, what to bring, what to ask for
- When and how to bring extended family into the conversation
Rooted in Barkley (2015) Parent Training and PMT (Parent Management Training) protocols.
Your child has rights. We help you use them.
Most countries with formal special-education frameworks recognise ADHD as a condition eligible for reasonable accommodations. IDEA and Section 504 in the US, JCQ Access Arrangements in the UK, IB's Inclusive Assessment Arrangements globally, CBSE / ICSE / RPWD Act 2016 in India, and equivalent frameworks in most other national systems. Our care team helps you access what your child is entitled to.
- Medical documentation formatted for your child's specific school system
- Accommodation letter for extra time, scribes, alternative formats
- Written communication plan for teachers and school counsellor
- Guidance on informing (or not informing) the school
- Support for university-entry exam accommodations (SAT, ACT, JEE, NEET, UCAT and others)
- Advocacy templates if the school is unresponsive
- Coordination with school counsellor or special educator
Frameworks referenced: IDEA / Section 504 (US) · JCQ Access Arrangements (UK) · IB Inclusive Assessment · CBSE / ICSE Circulars · RPWD Act 2016 (India) · and equivalent national frameworks.
School Accommodations · Worldwide
Getting accommodations at your child's school system.
Every major education system has a documented process for granting accommodations to students with ADHD, specific learning disabilities, or other neurodevelopmental conditions. Here's the step-by-step for the five most common systems our families navigate — with the exact documents you'll need.
🎓 IB & IGCSE Accommodations
- Psychoeducational assessment from a qualified psychologist within the past 3 years (IB and Cambridge are strict on recency).
- School's IB / Cambridge coordinator submits the "Inclusive Assessment Arrangements" (IB) or "Access Arrangements" (Cambridge IGCSE) form.
- Submission to IB HQ (Geneva) or Cambridge (UK) — done by the school, not by parents directly.
- Approval decision is centralised and applied globally, valid for a set exam session — usually 6-8 weeks turnaround.
- Higher documentation bar than many national systems — expect detailed clinical and educational evidence.
🎓 US Public Schools · IEP or 504 Plan
- Formal diagnosis from a licensed clinical psychologist or child psychiatrist stating ADHD (with DSM-5 criteria).
- Request evaluation in writing to the school district's Special Education Coordinator (protected under IDEA / Section 504 of the Rehabilitation Act).
- School conducts eligibility assessment within 60 days — reviews academic impact, teacher input, and clinical documentation.
- IEP or 504 meeting — parents, teachers, counsellor, and administrator draft the plan. You have the right to bring an outside advocate or advisor.
- Plan is implemented and reviewed annually (504) or every 1-3 years (IEP), with ongoing monitoring.
🎓 UK Schools · GCSE / A-Level Access Arrangements
- Educational Psychologist assessment or Specialist Assessor report identifying substantial impairment.
- School's SENCo (Special Educational Needs Coordinator) reviews and files evidence via JCQ's Access Arrangements Online (AAO) system.
- Normal Way of Working — accommodations must reflect how the student learns day-to-day, not just for exams.
- Application submitted to Joint Council for Qualifications (JCQ) before the exam series.
- Approval granted for the qualification cycle; reviewed each Key Stage.
🎓 CBSE & ICSE (India)
- Formal diagnostic report from a certified clinical psychologist or child psychiatrist mentioning ADHD (F90.x) or specific learning disability with DSM-5 / ICD-10 codes.
- Disability certificate under the RPWD Act 2016 from an authorised medical board (typically at district hospital) — required for >40% disability accommodations.
- Submit to school at the start of each academic year with a formal accommodation request letter from parent + medical documentation.
- School submits to CBSE / CISCE Regional Office before the exam registration deadline (usually October-November for March boards).
- Board evaluates & grants accommodations per its Circular on Facilities to Children with Special Needs. Response typically within 30-45 days.
🎓 Competitive & University-Entry Exams (SAT, ACT, UCAT, JEE, NEET)
- Formal disability documentation — most testing agencies (College Board for SAT, ACT Inc., etc.) have specific documentation formats.
- Request accommodations well in advance — deadlines are typically 6-12 weeks before test date.
- Upload documents via the agency's accommodations portal at registration.
- Review and confirmation — some agencies pre-approve for the whole cycle, others exam-by-exam.
- Accommodations applied per the testing agency's guidelines for candidates with disabilities.
Our care team prepares documentation formatted to your child's school or exam system requirements.
Common ADHD Myths in Indian Households
Myth vs. Fact · the ADHD edition.
Some of the most damaging things said to families of children with ADHD come from a lack of understanding, not ill will. Here are the eight myths we hear most often — and what the evidence actually says.
"ADHD is just modern parenting — spare the rod, spoil the child."
ADHD has ~74% heritability per twin studies (NICE NG87). It's neurodevelopmental, documented for over 100 years, and exists in every culture studied.
"He'll grow out of it — my cousin was like this and turned out fine."
60-70% of children with ADHD continue to have symptoms into adulthood (Sibley et al., 2016). Early intervention significantly improves lifetime outcomes.
"Medication is a shortcut — real change comes from discipline."
Medication treats a biological difference in the prefrontal cortex — it's no more a "shortcut" than glasses are for a child who can't see the board.
"Too much sugar / phone / video games causes ADHD."
None of these cause ADHD. They can worsen symptoms in a child who already has it — but the underlying biology is present at birth.
"Girls don't get ADHD — it's a boy thing."
Girls have ADHD at similar rates but are often missed because they present as inattentive (daydreamers) rather than hyperactive. Under-diagnosis in girls is well-documented.
"If she can focus on TikTok, she doesn't have ADHD."
Interest-based attention is a hallmark of ADHD. Highly stimulating novelty (short videos) is easy to focus on; sustained effort on boring tasks is exactly what's hard.
"ADHD medication is addictive and causes drug abuse."
Multiple large studies show properly-managed stimulant treatment in childhood actually reduces later substance-abuse risk (Wilens et al., 2003, Pediatrics).
"ADHD is over-diagnosed — everyone claims it now."
Most countries actually show under-diagnosis, especially in girls, adults, and non-white populations. Global community-prevalence studies consistently exceed formal diagnosis rates.
The Global ADHD Reality
ADHD worldwide · what the numbers say.
ADHD is one of the most common childhood neurodevelopmental conditions worldwide — and one of the most under-recognised. Here's the global picture, and what shapes access to care across regions.
📊 Global Prevalence & Access
🌍 What Shapes Access to Good ADHD Care
- Specialist scarcity — child psychiatrists are in short supply globally. Many families in smaller cities, towns and rural areas have no local specialist at all.
- Stigma varies but exists everywhere — mental-health diagnoses still carry social weight in many cultures, leading families to delay evaluation or seek "alternative" explanations.
- Cost of care — even in well-resourced healthcare systems, ADHD care is often only partially covered by insurance. Long-term costs add up quickly.
- Academic pressure — high-stakes school systems (competitive exams, university entry) amplify ADHD-related struggles and often trigger anxiety comorbidity earlier.
- Language of care — families are often more comfortable discussing symptoms in their first language. HopeQure specialists cover English, Hindi, Spanish, Arabic, Mandarin, French and 8 more.
- Family dynamics — extended-family and multi-generational households (common globally) often require the whole family to be part of the treatment plan, not just the parents.
- Telehealth solves geography — high-quality online ADHD care is now backed by strong evidence and works especially well for families far from urban specialists.
Sources: Polanczyk G. et al. The worldwide prevalence of ADHD: a systematic review and meta-regression. Am J Psychiatry (2007) · Sibley M.H. et al. J Child Psychol Psychiatry (2016) · WHO Mental Health Atlas · Faraone S. et al. Nature Rev Dis Primers (2015).
A Family's Journey · Sample
What integrated ADHD care looks like.
Illustrative outcome ranges typical for the AAP-guideline multimodal treatment approach (behaviour therapy + parent training + school support ± medication). Individual results vary.
The Complete ADHD Assessment Toolkit
Every validated instrument · what they measure, what they cost, what we use.
A structured ADHD evaluation is not one questionnaire — it's a battery of validated tools that triangulate symptoms, function, executive skills, and comorbidity. Here's the full landscape: which are free, which are proprietary, what each is best for, and which ones your HopeQure evaluation actually uses.
| Instrument | Measures | Ages · Items | Rater | Cost | Evidence base | We use it |
|---|---|---|---|---|---|---|
| NICHQ Vanderbilt Assessment Scales(VADRS) | DSM-5 ADHD symptoms · ODD · CD · Anxiety/Depression · Performance | 6-12 · 55 items (parent) / 43 items (teacher) | Parent + Teacher versions | Free · Public domain | Wolraich 2003 · AAP-endorsed for primary-care ADHD assessment | Core |
| SNAP-IV(Swanson, Nolan & Pelham v4) | DSM-5 ADHD + ODD symptoms · 3 subscales | 6-18 · 26 items (short) / 90 items (full) | Parent + Teacher | Free · Public use | Bussing 2008 US community norms · widely used in MTA study | Optional |
| WFIRS-P / WFIRS-S(Weiss Functional Impairment Rating) | Functional impact across 6 domains: family, school, life skills, self-concept, social, risky | 6-17 · 50 items (P) / 5-11 items self | Parent + Self-report | Free · Public use | Weiss 2007 · sensitive to treatment change | Core |
| Conners 3(Comprehensive Behavior Rating) | ADHD + comorbid disorders (ODD, CD, anxiety, depression, LD) | 6-18 · 110 items (full) / 45 items (short) / 10 items (index) | Parent + Teacher + Self (8+) | Proprietary · MHS Inc. | Conners 2008 · large normative sample · gold-standard broadband rating | On request |
| ADHD Rating Scale-5(ADHD-RS-5) | DSM-5 ADHD symptoms + impairment ratings | 5-17 · 30 items (18 symptom + 6 home + 6 school impairment) | Parent + Teacher | Proprietary · Guilford | DuPaul 2016 · psychometrically strong · widely used in trials | On request |
| BRIEF-2(Behavior Rating Inventory of Executive Function) | 9 executive-function scales: inhibit, shift, emotional control, self-monitor, initiate, working memory, plan/organize, task monitor, organize materials | 5-18 · 63 items (parent/teacher) / 55 (self) | Parent + Teacher + Self (11+) | Proprietary · PAR Inc. | Gioia 2015 · standard for EF measurement in ADHD, ASD, TBI | Core |
| CBCL(Child Behavior Checklist · Achenbach ASEBA) | Broadband: 8 syndrome scales, DSM-oriented scales, competence scales — screens ADHD alongside anxiety, depression, aggression, thought problems | 1.5-5 (preschool) · 6-18 (school) · 118 items | Parent + Teacher (TRF) + Self (YSR) | Proprietary · ASEBA | Achenbach 2001 · most-cited child mental-health instrument globally | On request |
| BASC-3(Behavior Assessment System for Children) | Broadband: clinical, adaptive & content scales including attention, hyperactivity, learning, executive function | 2-25 · 100-175 items depending on form | Parent + Teacher + Self | Proprietary · Pearson | Reynolds 2015 · used in schools + clinical settings | On request |
| Conners CPT-3(Continuous Performance Test) | Objective attention & response-inhibition performance · complements rating scales | 8+ · 14-min computerised task | Direct-administered | Proprietary · MHS Inc. | Conners 2014 · adds objective data to subjective ratings | When indicated |
| CGAS(Children's Global Assessment Scale) | Overall psychological, social and school functioning · single 1-100 score | 4-16 · clinician rating | Clinician | Free · Public use | Shaffer 1983 · standard global-function measure in child psychiatry | Core |
| K-SADS-PL(Kiddie Schedule for Affective Disorders & Schizophrenia) | Semi-structured diagnostic interview across ~30 childhood disorders including ADHD, ODD, CD, anxiety, mood, psychosis | 6-18 · 60-90 min interview | Clinician-administered | Free · Research use | Kaufman 1997 · gold-standard child psychiatric interview | Complex cases |
| DISC-IV(Diagnostic Interview Schedule for Children) | Structured diagnostic interview mapping to DSM-5 disorders | 6-17 · 60-90 min | Clinician / parent + child | Free · NIMH-developed | Shaffer 2000 · widely used in epidemiological studies | On request |
| Adult ADHD Self-Report (ASRS-v1.1)(WHO) | Adult DSM-5 ADHD screening (parent version for reflection on own symptoms) | 18+ · 6-item screener / 18-item full | Self-report | Free · WHO | Kessler 2005 · WHO endorsed · high sensitivity | Parents (adult tab) |
| HSQ & SSQ(Home & School Situations Questionnaires) | Setting-specific behavioural difficulty · 16 home / 12 school situations | 4-17 · 16-28 items | Parent / Teacher | Free · Barkley | Barkley 1987 · captures situational context | Follow-up |
A full HopeQure ADHD evaluation typically includes: Vanderbilt parent + teacher forms, WFIRS-P for functional impact, BRIEF-2 for executive function, CGAS for global functioning, plus structured clinical interview. CPT-3, Conners 3 or K-SADS-PL added when clinically indicated. Screening tools cost nothing; the value is in interpretation and integration — which is what your clinician does in a structured evaluation.
ADHD By The Numbers · Research Deep-Dive
The evidence base · with citations.
ADHD is one of the most researched conditions in child mental health. Below is the current evidence — organised by category — pulled from meta-analyses, large registry studies, and international consensus documents. Every number is cited.
Long-Term Outcomes · Landmark Registry Studies
What the largest datasets in the world show about treated vs untreated ADHD.
Nordic countries (Sweden, Denmark) maintain complete population registries linking healthcare, criminal justice, education, and mortality data over decades. These datasets have produced the strongest evidence in the field on real-world outcomes of ADHD medication — with sample sizes running into the hundreds of thousands.
🚗 Motor-vehicle crashes
⚖ Criminality
🍺 Substance use disorder
🏥 Unintentional injuries
💀 All-cause mortality
🎓 Academic achievement
💔 Suicide attempts
❤ Cardiovascular safety
Landmark ADHD Studies · A Reference Timeline
The studies that built the field.
Every clinical recommendation on this page traces back to specific pieces of research. Below is a curated timeline of the most influential ADHD studies — the ones that changed how the condition is understood, diagnosed, and treated. Use it to check the evidence base of any claim, anywhere.
| Year | Authors · Journal | Design · N | Key Finding · Clinical Implication |
|---|---|---|---|
| 1999 | MTA Cooperative GroupArch Gen Psychiatry | RCT · N=579 · 14 mo | Combined medication + behavioural treatment superior to either alone for ADHD symptoms and functioning. Defined multimodal care. |
| 2004 | Greenhill L. et al.Am J Psychiatry | PATS · N=303 preschoolers | Preschool ADHD Treatment Study — established behaviour therapy as first-line before medication in 4-5 year olds. Basis for AAP preschool recommendation. |
| 2007 | Jensen P. et al.J Am Acad Child Adolesc Psychiatry | MTA 36-mo N=436 | 3-year MTA follow-up: initial medication advantage narrowed once children in behavioural arm caught up. Treatment adherence more important than modality. |
| 2009 | Molina B. et al.J Am Acad Child Adolesc Psychiatry | MTA 8-yr follow-up | 8-year outcomes similar across original treatment groups, but ADHD group had worse outcomes than non-ADHD peers across all domains. ADHD is chronic; ongoing care matters. |
| 2016 | Hechtman L. et al.J Am Acad Child Adolesc Psychiatry | MTA 16-yr N=515 | 16-year MTA outcomes: adults with childhood ADHD had worse educational, occupational, and health outcomes vs local normative comparators — even when treated. |
| Year | Authors · Journal | Design · N | Key Finding · Clinical Implication |
|---|---|---|---|
| 2013 | APADSM-5 | Consensus revision | Onset age raised from 7 to 12; adult diagnostic threshold lowered to 5 symptoms; comorbid ASD permitted. Reflects lifespan reality of ADHD. |
| 2019 | Wolraich M. et al. (AAP)Pediatrics | Guideline update | Updated ages: evaluation from age 4; behaviour therapy first-line for preschoolers; behaviour therapy + medication for school-age; screening for comorbidities is now mandatory not optional. |
| 2019 | NICENG87 update | Guideline | UK guideline: no ADHD medication for preschoolers; environmental strategies first-line; medication for school-age only if severe or non-response to non-pharm strategies. |
| 2021 | Faraone S. et al.Neurosci Biobehav Rev | 208 conclusions | World Federation of ADHD International Consensus Statement — 208 evidence-based conclusions endorsed by 79 authors and 80 international organisations. Definitive current reference. |
| Year | Authors · Journal | Design · N | Key Finding · Clinical Implication |
|---|---|---|---|
| 2007 | Shaw P. et al.PNAS | Longitudinal MRI · N=446 | ADHD brains show ~3-year delay in cortical maturation, peaking around age 10.5 vs 7.5 in controls. Establishes ADHD as neurodevelopmental, not motivational. |
| 2009 | Volkow N. et al.JAMA | PET · N=53 | Dopamine transporter and D2/D3 receptor availability lower in ADHD brain reward circuit — biological basis for motivation and reward-response differences. |
| 2017 | Hoogman M. et al.Lancet Psychiatry | ENIGMA-ADHD · N=3,242 | Largest ADHD brain-imaging study: smaller amygdala, accumbens, caudate, hippocampus, putamen. Effect sizes small but robust across the lifespan. |
| 2023 | Demontis D. et al.Nat Genet | GWAS · N=225,534 | Updated GWAS: 27 genome-wide significant loci for ADHD (up from 12 in 2019). Polygenic architecture confirmed; overlap with education, brain volume, other conditions. |
| Year | Authors · Journal | Design · N | Key Finding · Clinical Implication |
|---|---|---|---|
| 2013 | Sonuga-Barke E. et al.Am J Psychiatry | Meta-analysis · 54 trials | Non-pharm interventions: only behavioural parent training and free-fatty-acid supplementation survived blinded rating criteria. Cognitive training and neurofeedback effects disappeared with blinding. |
| 2018 | Cortese S. et al.Lancet Psychiatry | Network meta-analysis · 133 RCTs · N=24,642 | Comparative efficacy/tolerability of 12 ADHD medications: methylphenidate best in children, amphetamines best in adults. Definitive contemporary reference. |
| 2018 | Storebø O. et al.Cochrane Database | Cochrane · 185 RCTs | Methylphenidate shows modest ADHD-symptom benefit but evidence quality often low-to-moderate. Argues for more rigorous long-term trials. |
| 2020 | Kollins S. et al.Lancet Digital Health | RCT · N=348 | Adaptive video-game therapy (EndeavorRx) improved attention in 8-12 year olds with ADHD · became first FDA-cleared digital therapeutic for ADHD in June 2020. |
| Year | Authors · Journal | Design · N | Key Finding · Clinical Implication |
|---|---|---|---|
| 2012 | Lichtenstein P. et al.NEJM | Register · N=25,656 | ADHD medication reduces criminality by 32% in men, 41% in women during medicated periods. Within-individual comparison design. |
| 2014 | Chang Z. et al.JAMA Psychiatry | Register · N=17,408 | ADHD medication reduces serious transport-accident risk by 38-42% during medicated periods. Also reduces subsequent substance-use-disorder risk. |
| 2015 | Dalsgaard S. et al.Lancet Psychiatry | Danish register · N=4,557 | Medication reduces unintentional-injury ED visits by 9-43% during treated periods. Effect on injuries seen across age bands and sexes. |
| 2022 | Sibley M.H. et al.Am J Psychiatry | MTA long-term · N=558 | 63.8% of childhood-ADHD adults showed a fluctuating course — challenges the "you outgrow ADHD" narrative. Symptoms remit and re-emerge over 16 years. |
| 2024 | Li L. et al.JAMA | Swedish register · N=148,578 | ADHD medication associated with 19% reduction in all-cause and 25% reduction in unnatural-cause mortality over 14-year follow-up. |
Frequently Asked Questions
Parent questions we hear every day.
Direct answers to the things parents actually ask — not clinical jargon.
Free Parent Toolkit · Download & Use Tonight
Practical templates for everyday ADHD parenting.
Six evidence-based templates our clinicians use with families every week. Free to download, adapt to your child, and print. No account required.
Behaviour Reward Chart
Weekly chart with 3 target behaviours + daily-star tracking + weekly reward menu. Based on Parent Management Training (Barkley 2015).
📥 DownloadHomework Routine Template
Structured after-school schedule with break timing, workspace setup checklist, and troubleshooting for common ADHD homework battles.
📥 DownloadSchool Accommodation Letter
Board-ready template letter to submit to your child's school with medical documentation. Pre-formatted per CBSE / ICSE norms.
📥 DownloadMorning & Bedtime Cards
Visual step-by-step routine cards for kids ages 5-12 — reduce morning chaos with cues instead of nagging.
📥 DownloadMedication Tracking Log
If your child is on ADHD medication, this log helps you record dose, timing, effect, side effects, and appetite/sleep — for psychiatrist reviews.
📥 DownloadParent-Teacher Meeting Prep
Questions to ask, documents to bring, and phrases that work when discussing your child's ADHD with school leadership.
📥 DownloadDownload unlocks after a free 60-second sign-up. We use the sign-up to send you the templates + occasional research-backed parenting tips. Unsubscribe anytime.
Medical Review Board
Every clinical claim on this page has been reviewed by our medical board — clinicians with active practice, board certification, and specific training in child & adolescent mental health. Content is refreshed every 12 months or when significant new guidelines are published.
Dr. Preeti Sharma
Reviewed clinical content, medication section, and treatment approaches. Practises child & adolescent psychiatry on HopeQure.
HopeQure Clinical Board
Reviewed regulatory content across jurisdictions, HIPAA/GDPR/DPDP compliance, and cross-border prescribing safeguards.
HopeQure Editorial Standards
Content follows evidence-hierarchy: peer-reviewed research > guideline documents > expert consensus. No promotional claims.
📚 Full References Cited on This Page
- Wolraich M.L., Hagan J.F., Allan C., et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019;144(4):e20192528. (AAP)
- National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE Guideline NG87. 2018, updated 2019.
- Faraone S.V., Banaschewski T., Coghill D., et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818.
- Canadian ADHD Resource Alliance (CADDRA). Canadian ADHD Practice Guidelines. 4.1 ed. 2020.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). Washington DC: APA; 2022.
- Australian ADHD Professionals Association (AADPA). Australian Evidence-Based Clinical Practice Guideline for ADHD. 2022.
- Wolraich M.L., Lambert W., Doffing M.A., et al. Psychometric properties of the Vanderbilt ADHD Diagnostic Parent Rating Scale in a referred population. J Pediatr Psychol. 2003;28(8):559-568.
- Bussing R., Fernandez M., Harwood M., et al. Parent and Teacher SNAP-IV Ratings of ADHD Symptoms: Psychometric Properties and Normative Ratings from a School District Sample. Assessment. 2008;15(3):317-328.
- Weiss M.D., Wasdell M.B., Bomben M.M., et al. Weiss Functional Impairment Rating Scale — Parent Report (WFIRS-P). Neuropsychiatric Disease and Treatment. 2007.
- Gioia G.A., Isquith P.K., Guy S.C., Kenworthy L. Behavior Rating Inventory of Executive Function — Second Edition (BRIEF-2). PAR Inc.; 2015.
- Conners C.K. Conners 3rd Edition (Conners 3). Multi-Health Systems; 2008.
- DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale-5 for Children and Adolescents. Guilford Press; 2016.
- Achenbach T.M., Rescorla L.A. Manual for the ASEBA School-Age Forms & Profiles. University of Vermont; 2001.
- Reynolds C.R., Kamphaus R.W. Behavior Assessment System for Children — Third Edition (BASC-3). Pearson; 2015.
- Shaffer D., Gould M.S., Brasic J., et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231.
- Kaufman J., Birmaher B., Brent D., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS-PL). J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988.
- Kessler R.C., Adler L., Ames M., et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256.
- Barkley R.A., Edelbrock C. Assessing situational variation in children's problem behaviors: The Home and School Situations Questionnaires. In: Advances in Behavioral Assessment of Children and Families. JAI Press; 1987.
- Polanczyk G., de Lima M.S., Horta B.L., et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-948.
- Danielson M.L., Claussen A.H., Bitsko R.H., et al. ADHD prevalence among US children and adolescents in 2022. J Clin Child Adolesc Psychol. 2024;53(3):343-360.
- Simon V., Czobor P., Bálint S., et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204-211.
- Willcutt E.G. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490-499.
- Fayyad J., Sampson N.A., Hwang I., et al. The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord. 2017;9(1):47-65.
- Faraone S.V., Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019;24(4):562-575.
- Demontis D., Walters G.B., Athanasiadis G., et al. Genome-wide analyses of ADHD identify 27 risk loci. Nat Genet. 2023;55(2):198-208.
- Shaw P., Eckstrand K., Sharp W., et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA. 2007;104(49):19649-19654.
- Hoogman M., Bralten J., Hibar D.P., et al. Subcortical brain volume differences in participants with ADHD across children and adults: ENIGMA-ADHD collaboration. Lancet Psychiatry. 2017;4(4):310-319.
- Volkow N.D., Wang G.J., Kollins S.H., et al. Evaluating dopamine reward pathway in ADHD. JAMA. 2009;302(10):1084-1091.
- Faraone S.V., Asherson P., Banaschewski T., et al. Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers. 2015;1:15020.
- Nigg J.T. Environment, developmental origins, and ADHD. JAMA Pediatr. 2018;172(7):619-621.
- The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for ADHD. Arch Gen Psychiatry. 1999;56(12):1073-1086.
- Cortese S., Adamo N., Del Giovane C., et al. Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738.
- Sonuga-Barke E.J., Brandeis D., Cortese S., et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275-289.
- Storebø O.J., Pedersen N., Ramstad E., et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents. Cochrane Database Syst Rev. 2018;5(5):CD012069.
- Greenhill L., Kollins S., Abikoff H., et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD (PATS). J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284-1293.
- Kollins S.H., DeLoss D.J., Cañadas E., et al. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. Lancet Digital Health. 2020;2(4):e168-e178.
- Safren S.A., Sprich S., Mimiaga M.J., et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD: a randomized controlled trial. JAMA. 2010;304(8):875-880.
- Molina B.S.G., Hinshaw S.P., Swanson J.M., et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484-500.
- Hechtman L., Swanson J.M., Sibley M.H., et al. Functional adult outcomes 16 years after childhood diagnosis of ADHD: MTA results. J Am Acad Child Adolesc Psychiatry. 2016;55(11):945-952.
- Elia J., Ambrosini P., Berrettini W. ADHD characteristics: concurrent co-morbidity patterns in children & adolescents. Child Adolesc Psychiatry Ment Health. 2008;2(1):15.
- Jarrett M.A., Ollendick T.H. A conceptual review of the comorbidity of ADHD and anxiety: implications for future research and practice. Clin Psychol Rev. 2008;28(7):1266-1280.
- DuPaul G.J., Gormley M.J., Laracy S.D. Comorbidity of LD and ADHD: implications of DSM-5 for assessment and treatment. J Learn Disabil. 2013;46(1):43-51.
- Meinzer M.C., Pettit J.W., Viswesvaran C. The co-occurrence of ADHD and depression in children and adolescents: a meta-analytic review. Clin Psychol Rev. 2014;34(8):595-607.
- Cortese S., Faraone S.V., Konofal E., Lecendreux M. Sleep in children with ADHD: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 2013;52(8):784-796.
- Simonoff E., Pickles A., Charman T., et al. Psychiatric disorders in children with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921-929.
- Barkley R.A. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 4th ed. Guilford Press; 2015.
- Dawson P., Guare R. Executive Skills in Children and Adolescents. 3rd ed. Guilford Press; 2018.
- Sibley M.H., Swanson J.M., Arnold L.E., et al. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2016.
- Sibley M.H., Arnold L.E., Swanson J.M., et al. Variable patterns of remission from ADHD in the MTA. Am J Psychiatry. 2022;179(2):142-151.
- Lichtenstein P., Halldner L., Zetterqvist J., et al. Medication for ADHD and criminality. NEJM. 2012;367(21):2006-2014.
- Chang Z., Lichtenstein P., D'Onofrio B.M., et al. Serious transport accidents in adults with ADHD and the effect of medication. JAMA Psychiatry. 2014;71(3):319-325.
- Chang Z., Lichtenstein P., Halldner L., et al. Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry. 2014;55(8):878-885.
- Dalsgaard S., Nielsen H.S., Simonsen M. Consequences of ADHD medication use for children's outcomes. Lancet Psychiatry. 2015;2(8):702-709.
- Chen Q., Sjölander A., Runeson B., et al. Drug treatment for ADHD and suicidal behaviour: register based study. BMJ. 2014;348:g3769.
- Cooper W.O., Habel L.A., Sox C.M., et al. ADHD drugs and serious cardiovascular events in children and young adults. NEJM. 2011;365(20):1896-1904.
- Li L., Zhu N., Zhang L., et al. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA. 2024;331(10):850-860.
- Wilens T.E., Faraone S.V., Biederman J., Gunawardene S. Does stimulant therapy of ADHD beget later substance abuse? A meta-analytic review. Pediatrics. 2003;111(1):179-185.
- US Department of Education. Individuals with Disabilities Education Act (IDEA). Public Law 108-446. 2004.
- US Department of Health and Human Services. Section 504 of the Rehabilitation Act of 1973. 29 U.S.C. § 794.
- Joint Council for Qualifications (JCQ, UK). Access Arrangements and Reasonable Adjustments. Annual publication.
- International Baccalaureate Organization. Access and Inclusion Policy. Current edition.
- Government of India. Rights of Persons with Disabilities Act 2016.
- Government of India, MoHFW. Telemedicine Practice Guidelines 2020.
- Government of India. Mental Healthcare Act 2017 · Section 23.
- Government of India. Digital Personal Data Protection Act 2023.
This reference list is not exhaustive — ADHD is one of the most heavily researched conditions in child mental health with tens of thousands of published papers. Above are the specific studies whose findings or numbers are quoted on this page. For the definitive current-state-of-evidence overview, we recommend the World Federation of ADHD International Consensus Statement (Faraone et al. 2021, ref #3), which synthesises 208 evidence-based conclusions from 250+ meta-analyses and large studies.
Related Care Services
Common companions to ADHD care.
Because ADHD rarely travels alone, these related services often support the same family.
Your child's information stays your family's.
HopeQure is HIPAA and GDPR aligned, ISO 27001 certified, and follows the highest global standards for mental-health data confidentiality. Children's mental health records are treated with the highest sensitivity. Nothing goes to your child's school, extended family, or employer without your explicit written consent.
Online ADHD counselling — wherever your family is
Delivering evidence-based child & teen ADHD care worldwide via secure video consultation. Certified experts, adapted to your child's school system and family context.
Your child isn't a problem to fix. They need the right support.
Book a first consultation with a child ADHD specialist today. If the fit isn't right after your first session, we'll refund it — no questions asked.